'I was born a lower middle-class person, am one today and will die as one,' Billboard's International Power Player Devraj Sanyal tells Vanita Kohli-Khandekar.
Finance Minister P Chidambaram has blamed the US' biofuel policy of diverting food grains such as corn for producing bio-fuels for the spurt in food grain prices globally. He also said that lack of adequate regulations in the US sub-prime market has led to global financial uncertainties. He said the demand for staple food was on the rise, leading to higher prices, but diverting food for fuel had also contributed to increase in food prices. He called US' priorities lopsided.
I used to personally deliver beer to Indian restaurants in my car, says Lord Karan Billimoria.
Billionaire investor Rakesh Jhunjhunwala explains why he thinks Modi should be at the helm of India.
This move could cost $299 million a year for Indian pharma players.
The launch came after final approval from the US health regulator to manufacture the generic version of Lipitor at Ranbaxy's wholly owned Ohm Laboratories facility in New Brunswick, New Jersey, as well as market the product.
Nestle India resumed the production from Pantnagar.
The phrase 'salt to taste' is a misnomer in the Indian context.
USFDA consent decree reveals that firm will have to forego huge short-term opportunities for its generics.
A gamechanger for offices and factories, Shycocan, claims to be able to clear an area of 1000 square feet from coronavirus.
Neslte which did brisk business in India, with 30 per cent revenue coming from Maggi alone, has not taken a big hit.
The firm, however, said the anti-cholesterol tablets meant for the US market will be produced at its Mohali SEZ plant in Punjab and not at the three units banned by the US health regulator.
Drug-maker Ranbaxy Laboratories on Wednesday said it has signed an agreement with the US health regulator to lift a ban on the import of drugs from certain manufacturing plants in India and will pay up to $500 million to settle a case lodged by the Department of Justice.
The company had posted a consolidated net profit of Rs 323.31 crore (Rs 3.23 billion) in the same period last fiscal, Wockhardt Ltd said in a filing to the Bombay Stock Exchange.
The bitter political rivals -- the ruling LDF and the UDF -- close ranks in the state assembly to oppose the ban.
'If the RBI blesses us with a banking licence, we would like to launch a successful bank.'
New Zealand legend Glenn Turner is concerned about the impact of T20 cricket on the "more worthwhile forms" of the game and feels that the coronavirus-forced break is a good time to "reassess" the future of the sport. The 72-year-old Turner, who is also the former chairman of New Zealand's selection panel, believes that cricket administrators have "gone down a path of capitalism".
The highest water-use efficiency of more than $ 50 per cubic metre is in Oceania, Australia, New Zealand, Singapore, Israel, Denmark, Finland, and Great Britain while the lowest is in Central and South Asia, including India, at less than $ 10 per cubic metre.
A day before the start of the Budget session of Parliament, as many as 18 opposition parties, led by the Congress, the Nationalist Congress Party, the Shiv Sena and the Trinamool Congress, decided on Thursday to boycott the President's address to the joint sitting of both Houses in solidarity with the farmers protesting against the new farm laws.
One of the most important aspects of a shared space is maintaining a quiet and peaceful environment, says Prashant Garg.
Inspections only in domestic authorities' presence, visiting US drug regulator told
'I would recommend two parts to fiscal support. One, support the lower end of the society by direct intervention through ways such as direct benefit cash transfer. Second, give fiscal support to the stressed sectors in line with the Rs 3-lakh crore (Rs 3 trillion) emergency credit line guarantee norms'
Sun Pharmaceutical Industries said it has received approval from US health regulator to market generic Clarinex tablets and Tiazac capsules, used in treating nasal allergies and hypertension, respectively, in the American market.
United States Food and Drug Administration (USFDA) has given final approval to Glenmark Generics Inc for their abbreviated new drug application (ANDA) for Norgestimate and Ethinyl Estradiol tablets USP in the strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg, the company said in a statement.
The meetings were a sign of crisis management.
Five seeds that can help you lose weight.
If you are not eating enough of the right food, it can lead to deficiency of certain chemicals leading to anxiety and depression. Here are some tips on what to eat to avoid such a state.
While Mcleod Russel, ADF Foods, Indiabulls Real Estate, DCM Shriram and BSE have announced buyback through open market route, the remaining 23 companies plan to buy back their shares via tender offers
'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'
The fees for facility inspection of foreign companies have been reduced
Good nutrition, plenty of water and an active lifestyle works wonders for your body.
Food and Drug Authority Ghana said in a statement that officials of Bliss GVS Pharma of India and Ghanaian drug maker Tobinco Pharmaceuticals have apologised to it for importing 'fake malaria medicine' to Ghana to treat malaria in children.
The reasons given for the refusal include misbranding, adulteration, packaging, labelling, pesticides, unapproved products.
Approval was given by the United States Food and Drug Administration for an investigational new drug application for ZYGK1, Cadila Healthcare said in a filing to the Bombay Stock Exchange.
Orchid Chemicals & Pharmaceuticals on Monday said it has received US health regulator's approval to sell anti-epileptic levetiracetam tablets in the American market.
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
Drug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015
Given the school break, this is the peak travel season and companies catering to the 'friends and family' segment are expected to gain.
